Endothelial function markers in parkinsonian patients with hyperhomocysteinemia

Journal of Clinical Neuroscience

Volumn 12, Issue 6, 2005, Pages 669-672

  Bostantjopoulou, Sevasti ^a,d   Katsarou, Zoe ^a   Frangia, Theodora ^b   Hatzizisi, Olga ^c   Papazisis, Kostas ^c   Kyriazis, George ^c   Kiosseoglou, Gregory ^c   Kazis, Aristidis ^a  

^a G Papanikolaou Hospital   (Greece)

^b G Papanikolaou Hospital   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d NONE   (Greece)

Author keywords

Endothelial function; Homocysteine; Parkinson' disease

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BIOCHEMICAL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; LEVODOPA; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM LESION; ENZYME ACTIVITY; FEMALE; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

AGED; ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; E-SELECTIN; ENDOTHELIUM, VASCULAR; FASTING; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INTERCELLULAR ADHESION MOLECULE-1; LEVODOPA; MALE; MIDDLE AGED; NITRIC OXIDE; PARKINSON DISEASE; SUPEROXIDE DISMUTASE;

EID: 23944450854     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2004.09.012     Document Type: Article

References (39)

1. J.C. Chambers, M.D.I. Seddon, S. Shah, and J.S. Kooner Homocysteine - a novel risk factor for vascular disease JR Soc Med 94 2001 10 13
2. R. Clarke Members of the Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis JAMA 288 2002 2015 2022
3. C. Van Guldener, and C.D.A. Stehouwer Hyperhomocysteinemia, vascular pathology and endothelial dysfunction Semin Thromb Hemost 26 2000 281 289
4. G.J. Hankey, and J.W. Eikelboom Homocysteine and stroke Curr Opin Neurol 14 2001 95 102
5. W. Kuhn, R. Roebrock, H. Blom, D. van Oppenraaij, and T. Müller Hyperhomocysteinaemia in Parkinson's disease J Neurol 245 1998 811 812
6. W. Kuhn, R. Roebroek, and H. Blom Elevated plasma levels of homocysteine in Parkinson's disease Eur Neurol 40 1998 225 227
7. T. Müller, B. Werne, B. Fowler, and W. Kuhn Nigral endothelial dysfunction, homocysteine, and Parkinson's disease Lancet 354 1999 126 127
8. K. Yasui, H. Kowa, K. Nakaso, T. Takeshima, and K. Nakashima Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD Neurology 55 2000 437 440
9. F. Blandini, R. Fancellu, and E. Martignoni Plasma homocysteine and L-Dopa metabolism in patients with Parkinson's disease Clin Chem 47 2001 1102 1104
10. J.D. Rogers, A. Sanchez-Saffon, A.B. Frol, and R. Diaz-Arrastia Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease Arch Neurol 60 2003 59 64
11. J.W. Miller, J. Selhumb, M.R. Nadeau, C.A. Thomas, R.G. Feldman, and P.A. Wolf Effect of L-Dopa on plasma homocysteine in PD patients: relationship to B-vitamin status Neurology 60 2003 1125 1129
12. A. Korten, J. Lodder, F. Vreeling, A. Boreas, L. van Raak, and F. Kessels Stroke and idiopathic Parkinson's disease: Does a shortage of dopamine offer protection against stroke Mov Disord 16 2001 119 123
13. F. Mastaglia, R. Johnsen, and B. Kakulas Prevalence of stroke in Parkinson's disease: a postmortem study Mov Disord 17 2002 772 774
14. S. Fahn, R. Elton Members of UPDRS Development Committee S. Fahn C.D. Marsden D.B. Calne M. Goldstein Recent Developments in Parkinson's Disease vol. 2 1987 Macmillan Health Care Information Florham Park, NJ 153 163 293-304
15. S. Bostantjopoulou, G. Kyriazis, Z. Katsarou, G. Kiosseoglou, and A. Kazis Superoxide dismutase activity in early and advanced Parkinson's disease Funct Neurol 12 1997 63 68
16. P. Frosst, H.J. Blom, and R. Milos A canditate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase Nat Genet 10 1995 111 113
17. Müller, D. Woitalla, B. Fowler, and W. Kuhn 3-OMD and homocysteine plasma levels in parkinsonian patients J Neural Transm 109 2002 175 179
18. J.W. Miller, B. Shukitt-Hale, R. Villalobos-Molina, M.R. Nadeau, J. Selhub, and J.A. Joseph Effect of L-Dopa and the catechol - O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats Clin Neuropharmacol 20 1997 55 66
19. X.X. Liu, K. Wilson, and C.G. Charlton Effects of L-Dopa treatment on methylation in mouse brain: implications for the side effects of L-Dopa Life Sci 66 2000 2277 2288
20. S. Hirsh, M. Pia de la Maza, and P. Yanez Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation Clin Cardiol 25 2002 495 501
21. R.I. Eberhardt, and J. Losalzo Homocysteine and endothelial dysfunction K. Robinson Homocysteine and Vascular Disease 2000 Kluwer Academic Publishers Dordrecht 371 387
22. X.L. Wang, N. Duarte, and H. Cai Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital - based population Atherosclerosis 146 1999 133 140
23. M.M.H. El Kossi, and M.M. Zakhary Oxidative stress in the context of acute cerebrovascular stroke Stroke 31 2000 1889 1892
24. H. Nonaka, T. Tsujino, Y. Watari, N. Emoto, and M. Yokoyama Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine. Amelioration of homocysteine induced endoplasmic reticulum stress by taurine Circulation 104 2001 1165 1170
25. D. Lang, M.B. Kredan, and S.J. Moat Homocysteine - induced inhibition of endothelium - dependent relaxation in rabbit aorta: role for superoxide anions Arterioscler Thromb Vasc Biol 20 2000 422 427
26. R.J. Marttila, H. Lorentz, and U.K. Rinne Oxygen toxicity protecting enzymes in Parkinson's disease, Increase of superoxide dismutase - like activity in substantia nigra and basal nucleus J Neurol Sci 86 1998 321 331
27. J. Karla, A.H. Rajput, S.V. Mantha, and K. Prasad Serum antioxidant enzyme activity in Parkinson's disease Mol Cell Biochem 110 1992 165 168
28. K. Urakami, K. Sano, and E. Matsushima Decreased superoxide dismutase activity in erythrocytes in Parkinson's disease Jpn J Psychiatry Neurol 46 1992 933 936
29. G.R. Upchurch Jr., G.N. Welch, A.J. Fabian, A. Pigazzi, J.F. Keaney Jr., and J. Loscalzo Stimulation of endothelial nitric oxide production by homocysteine Atherosclerosis 132 1997 177 185
30. G.R. Upchurch Jr., G.N. Welch, and A.J. Fabian Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase J Biol Chem 272 1997 17012 17017
31. J.C. Chambers, A. McGregor, J. Jean-Marie, and J.S. Kooner Acute hyperhomocysteinemia and endothelial dysfunction Lancet 351 1998 36 37
32. K.S. Woo, P. Chook, and V.I. Lolin Hyperhomocysteinemia is a risk factor for arterial endothelial dysfunction in human Circulation 96 1997 2542 2544
33. A. Tawakol, T. Omland, M. Gerhard, J.T. Wu, and M.A. Creager Hyperhomocysteinemia is associated with impaired endothelium - dependent vasodilation in humans Circulation 95 1997 1119 1121
34. G.W. De Valk-de Roo, C.D.A. Stehouwer, and J. Lambert Plasma homocysteine is weakly correlated with plasma endothelin and von Willebrand factor, but not with endothelium-dependent vasodilation in healthy postmenopausal women Clin Chem 45 1999 1200 1205
35. M.L. Selley Increased concentrations of homocysteine and asymmetric dimethyl-arginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease Neurobiol Aging 24 2003 903 907
36. G. Wang, C.W.H. Woo, F.L. Sung, Y.L. Siow, and O. Karmin Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia Arterioscler Thromb Vasc Biol 22 2002 1777 1783
37. M.D. Silverman, R.J. Tumuluri, M. Davis, G. Lopez, J.T. Rosenbaum, and P.I. Lelkes Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion Arterioscler Thromb Vasc Biol 22 2002 587 592
38. C.L. Chao, T.L. Kuo, and Y.T. Lee Effects of methionine - induced hyperhomocysteinemia on endothelium - dependent vasodilation and oxidative status in healthy adults Circulation 101 2000 485 490
39. A. Becker, W. Van Hinsbergh, and P.J. Kostense Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule 1, but not with C-reactive protein in type 2 diabetic and non-diabetic subjects - The Hoorn Study Eur J Clin Invest 30 2000 763 770